These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 34672802)

  • 21. Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2.
    Krsak M; Harry BL; Palmer BE; Franco-Paredes C
    Viral Immunol; 2021 Oct; 34(8):504-509. PubMed ID: 34227891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
    Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriate Sampling and Longer Follow-Up Are Required to Rigorously Evaluate Longevity of Humoral Memory After Vaccination.
    Ganusov VV
    Immunohorizons; 2024 Jun; 8(6):397-403. PubMed ID: 38864816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response.
    Bonelli MM; Mrak D; Perkmann T; Haslacher H; Aletaha D
    Ann Rheum Dis; 2021 Oct; 80(10):1355-1356. PubMed ID: 33958323
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
    N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.
    Connolly CM; Teles M; Frey S; Boyarsky BJ; Alejo JL; Werbel WA; Albayda J; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ
    Ann Rheum Dis; 2022 Feb; 81(2):291-293. PubMed ID: 34493492
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunity to glycan α-Gal and possibilities for the control of COVID-19.
    la Fuente J; Gortázar C; Cabezas-Cruz A
    Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
    Tenforde MW; Link-Gelles R; Patel MM
    JAMA; 2022 Oct; 328(14):1402-1404. PubMed ID: 36156638
    [No Abstract]   [Full Text] [Related]  

  • 30. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
    Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
    de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
    Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.
    Connolly CM; Chiang TP; Boyarsky BJ; Ruddy JA; Teles M; Alejo JL; Massie A; Werbel WA; Shah AA; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ
    Ann Rheum Dis; 2022 Feb; 81(2):293-295. PubMed ID: 34556484
    [No Abstract]   [Full Text] [Related]  

  • 33. Germinal Center-Induced Immunity Is Correlated With Protection Against SARS-CoV-2 Reinfection But Not Lung Damage.
    Kim G; Kim DH; Oh H; Bae S; Kwon J; Kim MJ; Lee E; Hwang EH; Jung H; Koo BS; Baek SH; Kang P; An YJ; Park JH; Park JH; Lyoo KS; Ryu CM; Kim SH; Hong JJ
    J Infect Dis; 2021 Dec; 224(11):1861-1872. PubMed ID: 34718664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.
    Finch E; Lowe R; Fischinger S; de St Aubin M; Siddiqui SM; Dayal D; Loesche MA; Rhee J; Beger S; Hu Y; Gluck MJ; Mormann B; Hasdianda MA; Musk ER; Alter G; Menon AS; Nilles EJ; Kucharski AJ;
    PLoS Biol; 2022 Feb; 20(2):e3001531. PubMed ID: 35143473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
    Deng Y; Li Y; Yang R; Tan W
    Cell Mol Immunol; 2021 Aug; 18(8):2040-2041. PubMed ID: 34267334
    [No Abstract]   [Full Text] [Related]  

  • 36. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse.
    Sanaie S; Golipour E; Shamekh A; Sadaie MR; Mahmoodpoor A; Yousefi M
    Int Immunopharmacol; 2021 Nov; 100():108108. PubMed ID: 34521025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response.
    Ostadgavahi AT; Booth R; Sisson G; McMullen N; Warhuus M; Robertson P; Miller M; Allen WC; El Sherif M; Brownlie R; Falzarano D; Richardson CD
    J Infect Dev Ctries; 2021 May; 15(5):653-656. PubMed ID: 34106888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times.
    Bachelet T; Bourdenx JP; Martinez C; Mucha S; Martin-Dupont P; Perier V; Pommereau A
    PLoS One; 2021; 16(10):e0257646. PubMed ID: 34610031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding protection from SARS-CoV-2 by studying reinfection.
    Overbaugh J
    Nat Med; 2020 Nov; 26(11):1680-1681. PubMed ID: 33093682
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2" by Krsak
    Mungmunpuntipantip R; Wiwanitkit V
    Viral Immunol; 2021 Oct; 34(8):582. PubMed ID: 34491120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.